INS and Hyperglycemia: Incidence of preterm births reported with metformin use in some of the studies were mostly at 33–35 week of gestation [20], [23] which may be an acceptable risk comparing adverse outcomes of hyperglycemia during pregnancy especially in a situation e.g. developing countries where availability of insulin could be an issue.